世界のナチュラルキラー細胞治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Natural Killer Cells Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4555 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ナチュラルキラー細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NK細胞治療、NK細胞指向抗体）、用途別市場規模（研究センター・研究所・病院・その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ナチュラルキラー細胞治療の市場動向 ・企業の競争状況、市場シェア ・ナチュラルキラー細胞治療の種類別市場規模と予測2016-2027（NK細胞治療、NK細胞指向抗体） ・ナチュラルキラー細胞治療の用途別市場規模と予測2016-2027（研究センター・研究所・病院・その他） ・ナチュラルキラー細胞治療の北米市場規模2016-2027（アメリカ、カナダ） ・ナチュラルキラー細胞治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ナチュラルキラー細胞治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ナチュラルキラー細胞治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ナチュラルキラー細胞治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Affimed、Celgene Corporation、Fate Therapeutics、Fortress Biotech、Glycostem Therapeutics、Innate Pharma、Nantkwest、Nkarta Therapeutics、NKT Therapeutics、Ziopharm Oncology） ・結論

Natural Killer Cells Therapeutics are type of immune cell that has granules (small particles) with enzymes that can kill tumor cells or cells infected with a virus. A natural killer cell is a type of white blood cell. Also called NK cell and NK-LGL.

Market Analysis and Insights: Global Natural Killer Cells Therapeutics Market
The global Natural Killer Cells Therapeutics market size is projected to reach US$ 2792.8 million by 2027, from US$ 1401.7 million in 2020, at a CAGR of 9.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Natural Killer Cells Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Natural Killer Cells Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Natural Killer Cells Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Natural Killer Cells Therapeutics market.

Global Natural Killer Cells Therapeutics Scope and Market Size
Natural Killer Cells Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Natural Killer Cells Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies

Segment by Application
Research Centers & Institutes
Hospitals
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Affimed
Celgene Corporation
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cells Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Centers & Institutes
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Natural Killer Cells Therapeutics Market Perspective (2016-2027)
2.2 Natural Killer Cells Therapeutics Growth Trends by Regions
2.2.1 Natural Killer Cells Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Natural Killer Cells Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Natural Killer Cells Therapeutics Industry Dynamic
2.3.1 Natural Killer Cells Therapeutics Market Trends
2.3.2 Natural Killer Cells Therapeutics Market Drivers
2.3.3 Natural Killer Cells Therapeutics Market Challenges
2.3.4 Natural Killer Cells Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2020
3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer Cells Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer Cells Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2022-2027)

5 Natural Killer Cells Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Natural Killer Cells Therapeutics Market Size (2016-2027)
6.2 North America Natural Killer Cells Therapeutics Market Size by Type
6.2.1 North America Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
6.3 North America Natural Killer Cells Therapeutics Market Size by Application
6.3.1 North America Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
6.4 North America Natural Killer Cells Therapeutics Market Size by Country
6.4.1 North America Natural Killer Cells Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Natural Killer Cells Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Natural Killer Cells Therapeutics Market Size (2016-2027)
7.2 Europe Natural Killer Cells Therapeutics Market Size by Type
7.2.1 Europe Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
7.3 Europe Natural Killer Cells Therapeutics Market Size by Application
7.3.1 Europe Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
7.4 Europe Natural Killer Cells Therapeutics Market Size by Country
7.4.1 Europe Natural Killer Cells Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Natural Killer Cells Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type
8.2.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application
8.3.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region
8.4.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Natural Killer Cells Therapeutics Market Size (2016-2027)
9.2 Latin America Natural Killer Cells Therapeutics Market Size by Type
9.2.1 Latin America Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Natural Killer Cells Therapeutics Market Size by Application
9.3.1 Latin America Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Natural Killer Cells Therapeutics Market Size by Country
9.4.1 Latin America Natural Killer Cells Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Natural Killer Cells Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type
10.2.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application
10.3.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country
10.4.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Affimed
11.1.1 Affimed Company Details
11.1.2 Affimed Business Overview
11.1.3 Affimed Natural Killer Cells Therapeutics Introduction
11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.1.5 Affimed Recent Development
11.2 Celgene Corporation
11.2.1 Celgene Corporation Company Details
11.2.2 Celgene Corporation Business Overview
11.2.3 Celgene Corporation Natural Killer Cells Therapeutics Introduction
11.2.4 Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.2.5 Celgene Corporation Recent Development
11.3 Fate Therapeutics
11.3.1 Fate Therapeutics Company Details
11.3.2 Fate Therapeutics Business Overview
11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.3.5 Fate Therapeutics Recent Development
11.4 Fortress Biotech
11.4.1 Fortress Biotech Company Details
11.4.2 Fortress Biotech Business Overview
11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.4.5 Fortress Biotech Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Details
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Innate Pharma
11.6.1 Innate Pharma Company Details
11.6.2 Innate Pharma Business Overview
11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.6.5 Innate Pharma Recent Development
11.7 Nantkwest
11.7.1 Nantkwest Company Details
11.7.2 Nantkwest Business Overview
11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.7.5 Nantkwest Recent Development
11.8 Nkarta Therapeutics
11.8.1 Nkarta Therapeutics Company Details
11.8.2 Nkarta Therapeutics Business Overview
11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.8.5 Nkarta Therapeutics Recent Development
11.9 NKT Therapeutics
11.9.1 NKT Therapeutics Company Details
11.9.2 NKT Therapeutics Business Overview
11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.9.5 NKT Therapeutics Recent Development
11.10 Ziopharm Oncology
11.10.1 Ziopharm Oncology Company Details
11.10.2 Ziopharm Oncology Business Overview
11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
11.10.5 Ziopharm Oncology Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cells Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Natural Killer Cells Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Natural Killer Cells Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Natural Killer Cells Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Natural Killer Cells Therapeutics Market Share by Regions (2022-2027)
Table 10. Natural Killer Cells Therapeutics Market Trends
Table 11. Natural Killer Cells Therapeutics Market Drivers
Table 12. Natural Killer Cells Therapeutics Market Challenges
Table 13. Natural Killer Cells Therapeutics Market Restraints
Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Natural Killer Cells Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer Cells Therapeutics as of 2020)
Table 17. Ranking of Global Top Natural Killer Cells Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Natural Killer Cells Therapeutics Product Solution and Service
Table 21. Date of Enter into Natural Killer Cells Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Natural Killer Cells Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Natural Killer Cells Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Natural Killer Cells Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Natural Killer Cells Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Natural Killer Cells Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Natural Killer Cells Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Natural Killer Cells Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Affimed Company Details
Table 62. Affimed Business Overview
Table 63. Affimed Natural Killer Cells Therapeutics Product
Table 64. Affimed Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Affimed Recent Development
Table 66. Celgene Corporation Company Details
Table 67. Celgene Corporation Business Overview
Table 68. Celgene Corporation Natural Killer Cells Therapeutics Product
Table 69. Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Celgene Corporation Recent Development
Table 71. Fate Therapeutics Company Details
Table 72. Fate Therapeutics Business Overview
Table 73. Fate Therapeutics Natural Killer Cells Therapeutics Product
Table 74. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Fate Therapeutics Recent Development
Table 76. Fortress Biotech Company Details
Table 77. Fortress Biotech Business Overview
Table 78. Fortress Biotech Natural Killer Cells Therapeutics Product
Table 79. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Fortress Biotech Recent Development
Table 81. Glycostem Therapeutics Company Details
Table 82. Glycostem Therapeutics Business Overview
Table 83. Glycostem Therapeutics Natural Killer Cells Therapeutics Product
Table 84. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Glycostem Therapeutics Recent Development
Table 86. Innate Pharma Company Details
Table 87. Innate Pharma Business Overview
Table 88. Innate Pharma Natural Killer Cells Therapeutics Product
Table 89. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Innate Pharma Recent Development
Table 91. Nantkwest Company Details
Table 92. Nantkwest Business Overview
Table 93. Nantkwest Natural Killer Cells Therapeutics Product
Table 94. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Nantkwest Recent Development
Table 96. Nkarta Therapeutics Company Details
Table 97. Nkarta Therapeutics Business Overview
Table 98. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Nkarta Therapeutics Recent Development
Table 100. NKT Therapeutics Company Details
Table 101. NKT Therapeutics Business Overview
Table 102. NKT Therapeutics Natural Killer Cells Therapeutics Product
Table 103. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 104. NKT Therapeutics Recent Development
Table 105. Ziopharm Oncology Company Details
Table 106. Ziopharm Oncology Business Overview
Table 107. Ziopharm Oncology Natural Killer Cells Therapeutics Product
Table 108. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Ziopharm Oncology Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer Cells Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. NK Cell Therapies Features
Figure 3. NK Cell Directed Antibodies Features
Figure 4. Global Natural Killer Cells Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Research Centers & Institutes Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. Natural Killer Cells Therapeutics Report Years Considered
Figure 9. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Natural Killer Cells Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Natural Killer Cells Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Natural Killer Cells Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Natural Killer Cells Therapeutics Market Share by Players in 2020
Figure 14. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer Cells Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2020
Figure 16. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Natural Killer Cells Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Natural Killer Cells Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2016-2027)
Figure 38. China Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Natural Killer Cells Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 58. Celgene Corporation Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 59. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 60. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 61. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 62. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 63. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 64. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 65. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 66. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---